STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2328 by analyst upside · 2026-06-27
MDT
Medtronic plc
Healthcare · Market Cap $104B · P/E 21.7x
ANALYST PRICE TARGET
+21.0%
implied upside to consensus target
Current Price $80.98
Consensus Target $98.0
Bull Target $121.0
Bear Target $78.0
Analysts Covering 26
ANALYST CONSENSUS — BUY
Strong Buy
3
Buy
12
Hold
11
Sell
0
52-Week Low $73.31
52-Week High $106.33
YTD Return -15.0%
FUNDAMENTALS
Market Cap $104B
P/E Ratio (TTM) 21.7x
Forward P/E 12.6x
EPS (TTM) $3.73
PEG Ratio 1.58
Dividend Yield 3.56%
Revenue (TTM) $36.4B
Profit Margin 13.2%
52-WEEK RANGE
52-Week Low $73.31
52-Week High $106.33
Current Price $80.98
Bear Target $78.0
Bull Target $121.0
● Now $80.98 ● Target $98.0
TRADING DATA
Avg Volume 10.2M
YTD Return -15.0%
Analyst Count 26
Consensus Buy
Upside to Target +21.0%
Last Updated 2026-06-27

ANALYST SUMMARY

Medtronic plc (MDT) is currently trading at $80.98 with a Wall Street consensus price target of $98.0, implying potential upside of 21.0% over the next 12 months. 26 analysts currently cover MDT, with a consensus rating of Buy — 58% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $121.0, while the most cautious has a target of $78.0.

MDT operates in the Healthcare sector with a market capitalisation of $104B. The stock is down 15.0% year-to-date and is currently trading near the lower end of its 52-week range of $73.31 – $106.33.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MDT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Needham reit
Buy → Buy 2026-06-17 20% win rate (5 calls)
Goldman Sachs — Reiterated
Neutral → Neutral 2026-06-05 Building track record
Bernstein — Reiterated
Outperform → Outperform 2026-06-05 Building track record
UBS — Reiterated
Neutral → Neutral 2026-06-04 33% win rate (6 calls)
TD Cowen reit
Buy → Buy 2026-06-04 Building track record
RBC Capital reit
Outperform → Outperform 2026-06-04 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-06-04 Building track record
Leerink Partners — Reiterated
Outperform → Outperform 2026-06-04 29% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
out of 100
Coverage depth
0/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
0/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call — not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →